CRRT严重脓毒症与MODS邱海波PPT格式课件下载.ppt
- 文档编号:14810685
- 上传时间:2022-10-25
- 格式:PPT
- 页数:43
- 大小:2.35MB
CRRT严重脓毒症与MODS邱海波PPT格式课件下载.ppt
《CRRT严重脓毒症与MODS邱海波PPT格式课件下载.ppt》由会员分享,可在线阅读,更多相关《CRRT严重脓毒症与MODS邱海波PPT格式课件下载.ppt(43页珍藏版)》请在冰豆网上搜索。
160patswithARF:
DailyDailyvsvsevery-other-every-other-dayIHDdayIHDMeanMeanultrafiltrationultrafiltrationvolumevolumeDaily:
1.2Daily:
1.20.5L0.5LEvery-other-day:
3.5Every-other-day:
3.50.3L(0.3L(PP0.001).0.001).HypotensionHypotensionoccurredinoccurredinDaily:
5Daily:
52%2%Every-other-day:
25Every-other-day:
255%(5%(PP0.001)0.001)TimetorecoveryofrenalfunctionTimetorecoveryofrenalfunctionDaily:
9Daily:
92days2daysEvery-other-day:
16Every-other-day:
166Days6DaysPP=0.001=0.001NEnglJMed2002;
346:
305-310为什么为什么CRRTCRRT有助于肾脏功能的恢复?
有助于肾脏功能的恢复?
EffectofEffectofRRTdoseRRTdoseonrecoveryonrecoveryofrenalfunction?
ofrenalfunction?
P=NSRoncoCetal.EffectsofdifferentdosesinCVVHonoutcomesofARF:
AprospectiveRCT20ml/h/kg35/ml/kg/h45ml/kg/h95%92%90%N=425SurvivalLancet2000;
356:
26-30lCRRTvsIRRTonreturnofrenalfunctionOnmortalityMortality:
WhichisbetterCRRTorIHD?
Swzrtz.RD.ComparingcontinuousHFwithHDinpatientswithsevereARFAmJKidney1999;
34:
424-432Mehti.RL.CollaborativeGroupforTreatmentofARFinICU:
ARCTofcontinuousversusIHDforARF.KidneyInt2001;
60:
1154-63KellumJA.ContinuousversusintermittentRRT.Ameta-analysis.IntensiveCareMed2002;
162:
197-202Conclusion:
ThereisnoconclusiveevidencetosupportthesuperiorityofCRRTvsIHD.BothtechniquesarecomplimentaryCRRTvsIRRT对危重病患者的影响对危重病患者的影响CRRT可降低危重病患者病死率可降低危重病患者病死率nQualityscore5:
definitelyequalCRRTvsIRRT对危重病患者的影响对危重病患者的影响CRRT可降低危重病患者病死率可降低危重病患者病死率Hospitalmortality:
CRRTwasassociatedwithareducedriskofhospitaldeathinthesixstudiesinwhichbaselineseverityofillnesswassimilarRR0.48,0.340.69,p0.0005IntensiveCareMed,2002,28:
29-371.CRRTvsIRRT2.EarlyvslateCRRT3.Highvsnormalflow4.PossiblewaystoincreasemediatorsclearanceCurrentopinioninCRRTCurrentopinioninCRRT19891997:
100例创伤后ARF早期后期的临界:
BUN60mg/dl两组病人创伤评分、GCS、发生休克的比例、年龄、性别和创伤分布均无差异早期后期早期后期CRRT对危重病患者的影响对危重病患者的影响早期或预防性早期或预防性CRRT可降低可降低ARF患者病死率患者病死率GettingsLG.IntensiveCareMed,1999,25:
805-813早期后期早期后期CRRT对危重病患者的影响对危重病患者的影响早期或预防性早期或预防性CRRT可降低可降低ARF患者病死率患者病死率n生存率明显差异生存率明显差异GettingsLG.IntensiveCareMed,1999,25:
805-813OutcomeOutcomeEarlystart39%survivalEarlystart39%survivalLatestart20%survivalLatestart20%survivalEarlyvs.LateRRTRCT(n=106)Oliguria(30cc/hr)refractorytohigh-dosefurosemide(500mgover6hrs)Randomizedto3groups:
Early(12h)high-volumehemofiltration(n=35;
72-96L/24h)Early(5060ml/kg/hrOR:
60L/dincludingnetultrafiltrationincontinuoushemofiltrationmodeq目的:
目的:
评估高流量血滤对感染性休克患者评估高流量血滤对感染性休克患者(n-11)血流动力血流动力学和细胞因子的影响学和细胞因子的影响q方法:
方法:
随机随机cross-over试验,患者随机接受试验,患者随机接受8hHVHF(6L/h)(AN69滤器,滤器,1.6m2)或或8hCVVH(1L/h)(AN69滤器,滤器,1.2m2)q检测指标:
检测指标:
血流动力学、去甲肾上腺素需要量、血清血流动力学、去甲肾上腺素需要量、血清C3a、C5a、IL-2、IL-8、IL-10和和TNF的含量的含量HVHF组与组与CVVH组组CVP、CI、PAWP和液体平衡无差异和液体平衡无差异维持维持MAP70mmHg,HVHF组组NE剂量显著低于剂量显著低于CVVHNE剂量分别降低剂量分别降低10.5ug/min和和1.0ug/minP=0.02高流量血滤在感染性休克患者中的作用高流量血滤在感染性休克患者中的作用HVHF显著降低感染性休克显著降低感染性休克NE用量用量ColeL,etal.IntensiveCareMed,2001,27:
978-986MeanNorepinephrineDoseMeanC3aconcentrationMeanC5aconcentrationEffectofHVHFonmortalityOudemans-vanOudemans-vanStraatenStraatenHmHmetetal,al,IntensIntensCareCareMedMed1999;
25:
814-821.1999;
814-821.*=MadridARFscore*=MadridARFscoreHV-CVVHHV-CVVH明显改善感染性休克预后明显改善感染性休克预后脉冲式高容量血液滤过脉冲式高容量血液滤过(PulseHVHF)极高容量很难维持24h以上,而且对溶质动力学无明显改进Ranco提出了脉冲式高容量血液滤过SeminarsinDialysis,2006,19
(1):
69-746420PulseL/hHVHF-AssalvagetherapyinseveresepticshockObjectives:
ToevaluatetheeffectPHVHF(12-h)inreversingprogressiverefractoryhypotensioninpatswithsshockN=20sshockpatswithNE0.3g/kg.minandandlacticacidosisRespondersvsNon-R(NEandlactatelevelsat6hafterPHVHF)IntensiveCareMed(2006)32:
713722HigherHigherUfUfvolumesvolumesHighermembraneHighermembranecut-offcut-offPermeabilit
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- CRRT 严重 脓毒症 MODS 海波